Comp360 Psilocybin
Ptsd, Ptsd - Post Traumatic Stress Disorder, Ptsd Symptoms, Ptsd, Post Traumatic Stress Disorder
Phase II/III
Recruiting
Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder
Apr 30, 2026
―
Psilocybin
Major Depressive Disorder
Phase II
Active Not Recruiting
A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive Disorder
Feb 08, 2023
―
Psilocybin
Treatment Resistant Depression
Phase III
Active Not Recruiting
Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD
Nov 14, 2022
―
Psilocybin
Anorexia Nervosa
Phase II
Completed
Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept Study
Jul 28, 2022
―
Psilocybin
Post Traumatic Stress Disorder
Phase II
Completed
The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder
Mar 28, 2022
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does COMPASS Pathways (CMPSN) have in its pipeline
CMPSN is currently developing the following drugs: Comp360 Psilocybin, Psilocybin, Psilocybin. These drug candidates are in various stages of clinical development as the company works toward FDA approval.